Track market-moving stories before they get noisy

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Cervecerias Unidas (CCU - Free Report) and Ambev (ABEV - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Cervecerias Unidas has a Zacks Rank of #2 (Buy), while Ambev has a Zacks Rank of #4 (Sell) right now. This means that CCU's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one piece of the puzzle for value investors.

Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.

The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.

CCU currently has a forward P/E ratio of 14.90, while ABEV has a forward P/E of 15.15. We also note that CCU has a PEG ratio of 0.77. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ABEV currently has a PEG ratio of 1.80.

Another notable valuation metric for CCU is its P/B ratio of 1.09. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, ABEV has a P/B of 2.81.

These are just a few of the metrics contributing to CCU's Value grade of A and ABEV's Value grade of C.

CCU stands above ABEV thanks to its solid earnings outlook, and based on these valuation figures, we also feel that CCU is the superior value option right now.

Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Ambev (ABEV - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.

Ambev is one of 173 companies in the Consumer Staples group. The Consumer Staples group currently sits at #15 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Ambev is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ABEV's full-year earnings has moved 11.7% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the latest available data, ABEV has gained about 26.7% so far this year. Meanwhile, the Consumer Staples sector has returned an average of 8.2% on a year-to-date basis. This means that Ambev is performing better than its sector in terms of year-to-date returns.

Another Consumer Staples stock, which has outperformed the sector so far this year, is Chefs' Warehouse (CHEF - Free Report) . The stock has returned 53.4% year-to-date.

For Chefs' Warehouse, the consensus EPS estimate for the current year has increased 9.2% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Ambev belongs to the Beverages - Alcohol industry, a group that includes 14 individual stocks and currently sits at #175 in the Zacks Industry Rank. On average, stocks in this group have gained 17.7% this year, meaning that ABEV is performing better in terms of year-to-date returns.

In contrast, Chefs' Warehouse falls under the Food - Miscellaneous industry. Currently, this industry has 40 stocks and is ranked #196. Since the beginning of the year, the industry has moved -3.3%.

Ambev and Chefs' Warehouse could continue their solid performance, so investors interested in Consumer Staples stocks should continue to pay close attention to these stocks.

Posted by Defense World Staff on Apr 3rd, 2026

Eldred Rock Partners LLC cut its holdings in shares of Ambev S.A. (NYSE:ABEV – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,560,200 shares of the company’s stock after selling 401,846 shares during the quarter. Ambev comprises approximately 2.3% of Eldred Rock Partners LLC’s investment portfolio, making the stock its 26th biggest position. Eldred Rock Partners LLC’s holdings in Ambev were worth $8,794,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. CANADA LIFE ASSURANCE Co raised its holdings in Ambev by 74.8% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock valued at $32,624,000 after buying an additional 5,740,155 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Ambev by 12.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock worth $80,410,000 after buying an additional 3,864,844 shares during the period. Marshall Wace LLP increased its position in shares of Ambev by 192.7% during the second quarter. Marshall Wace LLP now owns 4,208,299 shares of the company’s stock valued at $10,142,000 after acquiring an additional 2,770,698 shares during the last quarter. Bank of America Corp DE raised its stake in shares of Ambev by 9.9% in the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock valued at $66,288,000 after acquiring an additional 2,479,310 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in shares of Ambev in the 2nd quarter valued at approximately $5,124,000. 8.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In A number of equities analysts recently weighed in on ABEV shares. Weiss Ratings raised shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, March 5th. Wall Street Zen cut Ambev from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Barclays raised their price target on Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 17th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $2.69.

Get Our Latest Research Report on ABEV

Ambev Trading Down 0.8% NYSE ABEV opened at $2.95 on Friday. The firm has a 50 day simple moving average of $2.95 and a 200-day simple moving average of $2.59. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96. Ambev S.A. has a one year low of $2.10 and a one year high of $3.24. The firm has a market cap of $46.41 billion, a price-to-earnings ratio of 16.36, a PEG ratio of 2.19 and a beta of 0.66.

Ambev (NYSE:ABEV – Get Free Report) last announced its earnings results on Friday, February 13th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The firm had revenue of $4.50 billion for the quarter, compared to the consensus estimate of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. Equities research analysts anticipate that Ambev S.A. will post 0.18 EPS for the current fiscal year.

Ambev Company Profile (Free Report)

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

Featured Stories Five stocks we like better than Ambev Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV – Free Report).

Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINETwist Bioscience Corporation (NASDAQ:TWST) Receives Average Rating of “Moderate Buy” from Analysts

NEXT HEADLINE »Eldred Rock Partners LLC Invests $6.18 Million in Pool Corporation $POOL

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.

However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Our proprietary system currently recommends Ambev (ABEV - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 1.3%, investors should actually focus on the projected growth. The company's EPS is expected to grow 5.6% this year, crushing the industry average, which calls for EPS growth of 3.8%.

Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric shows how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.53, it can be said that the company is more efficient.

In addition to efficiency in generating sales, sales growth plays an important role. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 14.7% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 2.7% over the past month.

Bottom LineAmbev has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that Ambev is a potential outperformer and a solid choice for growth investors.

© Tapati Rinchumrus / Shutterstock.com

The WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM) offers income investors about 4% dividend yield sourced entirely from companies in developing economies, packaged in a single fund with $3.5 billion in net assets. For investors tired of domestic dividend stalwarts, the appeal is real. But the income mechanics here deserve a close look before treating this as a reliable paycheck.

The iconic Octávio Frias de Oliveira Bridge anchors the financial district skyline of São Paulo, a prominent emerging market. How DEM Selects and Weights Its Dividend Payers DEM tracks a fundamentally weighted index of the highest dividend-yielding stocks across emerging markets. Rather than weighting by market cap, the fund allocates based on each company’s share of total dividends paid within the index universe. This approach naturally tilts the portfolio toward mature, cash-generative businesses in financials, energy, and consumer staples, sectors that have historically paid the most cash to shareholders in developing markets.

The fund holds over 500 individual securities, which sounds like broad protection. But concentration still exists at the top. China Construction Bank alone represents 4.5% of the portfolio, and the top 15 holdings account for roughly a quarter of total assets. Geographic exposure spans China, Taiwan, Brazil, Saudi Arabia, Poland, India, and a dozen other markets, each carrying its own currency, regulatory, and political risk.

The Two Highlighted Holdings: ABEV and UMC Two of the fund’s named holdings, Ambev (NYSE:ABEV | ABEV Price Prediction) and United Microelectronics (NYSE:UMC), sit at positions 15 and 13 respectively, each carrying weights of roughly 1%. Together they illustrate the structural tensions running through the entire portfolio.

Ambev, Brazil’s dominant brewer, paid roughly $0.20 per share in total USD dividends across 2025, which matches its reported EPS of $0.20 almost exactly. A payout ratio near 100% leaves no margin for earnings softness. The company’s operating cash flow fell 6.3% year over year, and its cash balance dropped nearly 35%. Currency is the deeper issue: Ambev earns in Brazilian reals, and the BRL currently trades near 0.20 per U.S. dollar, while the company hedges at a rate of 5.50 BRL/USD. When the real weakens beyond that hedge level, USD-denominated dividends shrink. The December 2025 year-end payment of $0.13 per share was meaningfully larger than the three smaller quarterly payments, meaning income is lumpy, not steady.

United Microelectronics, a Taiwanese semiconductor foundry, has a more encouraging dividend record. Annual payments grew from $0.14 in 2020 to $0.59 in 2023, then moderated to $0.48 in 2025. With EPS of $0.52, the payout ratio runs around 92%, which is elevated for a capital-intensive chipmaker. UMC guided for $1.5 billion in 2026 capital expenditure, and utilization sits in the mid-70% range, meaning the business is not running at peak efficiency. CEO Jason Wang stated, “Going into the first quarter of 2026, we expect wafer demand to remain firm.” That confidence supports near-term dividend continuity, though the high payout leaves little room for a demand miss.

Total Return and the Currency Drag Both holdings have delivered strong price recoveries recently. Ambev shares are up about 27% recently, and UMC has gained roughly 27% over the same period. That price appreciation is a meaningful part of the total return story for DEM holders, since the income alone carries real risks. The fund’s about 0.6% expense ratio erodes net yield meaningfully at the 4% income level.

The Verdict on DEM’s Income Stream DEM’s roughly 4.07% yield is real, but it is not stable. The fund’s income fluctuates with foreign currencies, corporate earnings cycles across a dozen emerging economies, and the dividend policies of companies operating under political and regulatory environments outside U.S. investor control. High payout ratios, currency translation risk, and lumpy payment schedules make budgeting around this income difficult.

Investors weighing DEM should understand that the yield comes bundled with variable quarterly distributions, currency translation risk across a dozen markets, and dividend policies set by companies operating under political and regulatory environments outside U.S. investor control. The gap between the fund’s headline yield and a U.S. Treasury reflects those risks directly.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.

However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Ambev (ABEV - Free Report) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.

Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 1.3%, investors should actually focus on the projected growth. The company's EPS is expected to grow 5.6% this year, crushing the industry average, which calls for EPS growth of 2.8%.

Impressive Asset Utilization RatioAsset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.53, it can be said that the company is more efficient.

While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 14.7% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 2.7% over the past month.

Bottom LineWhile the overall earnings estimate revisions have made Ambev a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that Ambev is a potential outperformer and a solid choice for growth investors.

The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Ambev (ABEV - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.

Ambev is a member of our Consumer Staples group, which includes 173 different companies and currently sits at #15 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Ambev is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ABEV's full-year earnings has moved 5.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the latest available data, ABEV has gained about 17.4% so far this year. Meanwhile, stocks in the Consumer Staples group have gained about 5.6% on average. This means that Ambev is performing better than its sector in terms of year-to-date returns.

Another Consumer Staples stock, which has outperformed the sector so far this year, is Chefs' Warehouse (CHEF - Free Report) . The stock has returned 26.5% year-to-date.

For Chefs' Warehouse, the consensus EPS estimate for the current year has increased 7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Ambev belongs to the Beverages - Alcohol industry, a group that includes 14 individual stocks and currently sits at #197 in the Zacks Industry Rank. On average, stocks in this group have gained 9.8% this year, meaning that ABEV is performing better in terms of year-to-date returns.

Chefs' Warehouse, however, belongs to the Food - Miscellaneous industry. Currently, this 41-stock industry is ranked #205. The industry has moved -2.5% so far this year.

Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to Ambev and Chefs' Warehouse as they could maintain their solid performance.

Ambev S.A. has sharply rebounded on improved Brazilian macro, BRL strength, and renewed EM equity appetite, supported by strong FY25 and 1Q26 results. ABEV outperformed the declining Brazilian beer industry in Q1, with Brazil Beer volumes up 1.2% and premium segment growth exceeding 20%. Cash flow generation reached a decade-high in Q1, enabling robust shareholder returns with a 5–6% yield, well above minimum payout requirements.

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV - Free Report) and Boston Beer (SAM - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Currently, Ambev has a Zacks Rank of #2 (Buy), while Boston Beer has a Zacks Rank of #4 (Sell). Investors should feel comfortable knowing that ABEV likely has seen a stronger improvement to its earnings outlook than SAM has recently. But this is just one piece of the puzzle for value investors.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.

ABEV currently has a forward P/E ratio of 17.59, while SAM has a forward P/E of 21.11. We also note that ABEV has a PEG ratio of 2.40. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. SAM currently has a PEG ratio of 2.66.

Another notable valuation metric for ABEV is its P/B ratio of 3.13. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, SAM has a P/B of 3.16.

These metrics, and several others, help ABEV earn a Value grade of B, while SAM has been given a Value grade of C.

ABEV has seen stronger estimate revision activity and sports more attractive valuation metrics than SAM, so it seems like value investors will conclude that ABEV is the superior option right now.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.

However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Our proprietary system currently recommends Ambev (ABEV - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.

While there are numerous reasons why the stock of this beverage company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Ambev is 0.6%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.8% this year, crushing the industry average, which calls for EPS growth of 2.8%.

Impressive Asset Utilization RatioAsset utilization ratio -- also known as sales-to-total-assets (S/TA) ratio -- is often overlooked by investors, but it is an important indicator in growth investing. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.

Right now, Ambev has an S/TA ratio of 0.62, which means that the company gets $0.62 in sales for each dollar in assets. Comparing this to the industry average of 0.48, it can be said that the company is more efficient.

While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Ambev is well positioned from a sales growth perspective too. The company's sales are expected to grow 19.1% this year versus the industry average of 0%.

Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The current-year earnings estimates for Ambev have been revising upward. The Zacks Consensus Estimate for the current year has surged 8.8% over the past month.

Bottom LineAmbev has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination positions Ambev well for outperformance, so growth investors may want to bet on it.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© jittawit21 / Shutterstock.com

Single digit share prices usually mean a broken business, a melting ice cube, or a speculative lottery ticket. Every once in a while though, the market hands you something genuinely strange: a household name with billions in cash flow and a serious dividend, trading for the price of a fancy coffee. With Wall Street nervous about Latin American currencies and Brazil’s interest rate environment, one of the biggest beverage businesses on the planet has quietly slipped into bargain territory.

With that setup, here is one stock trading under $5 that long-term, income-focused investors should be paying close attention to right now.

Ambev (NYSE: ABEV) Ambev (NYSE:ABEV | ABEV Price Prediction) is the Brazilian brewing and beverage giant behind Brahma, Skol, Antarctica, Stella Artois, Corona, Budweiser, and Michelob Ultra across Latin America, plus the licensed Pepsi business in Brazil and digital platforms BEES Marketplace and Zé Delivery.

Shares closed at $3.27 on May 21, 2026, which means a $500 grocery budget can buy you a meaningful stake in a company with a market cap near $50.92 billion. The stock is up 32.39% year to date and 39.23% over the past year, yet it still trades closer to the middle of its 52-week range of $1.988 to $3.45.

This infographic provides a snapshot of ABEV, highlighting its current price, analyst consensus, and price targets as a ‘Buy’ case stock trading under $5. The fundamentals tell you why this is more than a penny stock dressed up in a suit. Ambev generated $88.24 billion in FY2025 revenue and $15.99 billion in net income, up 10.74% year over year. The company trades at a trailing P/E of 16 and a forward P/E of 15, with a dividend yield of 4.79%. Analysts surveyed for the stock skew cautious overall: 1 Strong Buy, 1 Buy, 7 Hold, and 2 Sell ratings, with an average price target of $3.326, roughly in line with where shares trade today.

The bull case is straightforward. Buying market dominance at a single-digit share price is rare, and Ambev controls a functional monopoly over the Latin American beverage market. The company returned roughly $20 billion in dividends and buybacks for FY25, approved a new R$2.5 billion buyback authorizing up to 208 million shares, and re-elected its board through 2029. Premium brand volumes climbed 17% for the full year, non-alcohol beer volumes grew about 30% in Brazil, and Zé Delivery now does R$4.7 billion in GMV with 67 million yearly orders and 27 million active users. CEO Carlos Lisboa said “the strength of our brands and the consistent execution of our strategy drove mid-single-digit Normalized EBITDA growth with margin expansion, despite a dynamic environment”. The 2026 FIFA World Cup is the cherry on top: a global beer-drinking event landing right as Ambev enters the year with momentum.

The risk that cuts against this thesis is real. Goldman Sachs has maintained a Sell rating tied to Brazil’s cost-of-capital concerns, consolidated volumes fell 3.6% in Q4 and 3.3% for the full year, and management guided Brazil Beer Cash COGS per hectoliter up 4.5% to 7.5% in 2026. FX swings, aluminum costs, and Argentina’s hyperinflation are not going away. Currency fluctuations and temporary regional headwinds scare off short-sighted institutional funds, but the company’s massive scale, pristine balance sheet, and reliable cash generation yield a highly stable 4.5%+ dividend for value seekers.

For investors willing to look past short-term Brazil noise, Ambev offers a rare combination: regional dominance, real cash returns, and a single-digit share price that does the heavy lifting on entry cost.

One last reminder: Ambev’s case rests on its scale, its cash flow, and its dividend. The single-digit share price is just the entry cost, not the investment thesis itself. Do your own digging on the FX exposure and Brazilian macro picture before you decide whether this fits your portfolio.

Ambev S.A. recently rallied to a one-year high, with a subsequent pullback presenting renewed buying opportunities. ABEV's Q1 2026 showed resilience: operating revenue was stable, organic net revenue per hectoliter rose 8%, and operating margin improved to 26.5%. Inflation and shifting consumer preferences, especially among younger Americans, remain key risks, but ABEV's Brazilian market strength and diversification mitigate these concerns.